Search - tctmd.com

Displaying 1 - 20 of 53

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2024

Shelley Wood

December 03, 2024

News Conference News ESC 2024

Streamlined European AF Guidelines Emphasize ‘Whole’ Patient

Todd Neale

September 06, 2024

News Conference News ESC 2024

STEEER-AF: Educating Healthcare Workers Improves Adherence to Guidelines

Todd Neale

September 06, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

Registry Data Reassure on Safety With Next-Generation Watchman Device

L.A. McKeown

July 30, 2024

News Daily News

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Michael O'Riordan

July 09, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2024

Shelley Wood

February 01, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

L.A. McKeown

September 18, 2023

News Conference News ESC 2023

FRAIL-AF: Warfarin Beats NOACs in Frail Elderly With AF

Shelley Wood

August 28, 2023

News Conference News EuroPCR 2023

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

Todd Neale

May 18, 2023

News Daily News

Generic Dabigatran Lots Pulled for Nitrosamine Impurity

Michael O'Riordan

March 28, 2023

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

L.A. McKeown

December 16, 2022

Advertisement

TCTMD’s Top 10 Most Popular Stories for November 2024

Streamlined European AF Guidelines Emphasize ‘Whole’ Patient

STEEER-AF: Educating Healthcare Workers Improves Adherence to Guidelines

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

August 2024 Dispatch for the CV Team

Registry Data Reassure on Safety With Next-Generation Watchman Device

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

June 2024 Dispatch for the CV Team

May 2024 Dispatch for the CV Team

April 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for January 2024

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

October 2023 News Roundup

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

FRAIL-AF: Warfarin Beats NOACs in Frail Elderly With AF

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

Generic Dabigatran Lots Pulled for Nitrosamine Impurity

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content